Clinical Trials Directory

Trials / Completed

CompletedNCT01216579

Steroid Titration Against Mannitol IN Asthma

Titrating Inhaled Steroid Dose Against Mannitol Hyper-responsiveness or BTS Outcomes: Comparative Effects on Asthma Exacerbations Over 1 Year

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
164 (actual)
Sponsor
University of Dundee · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesise that titration of asthma medication against mannitol challenge results will reduce the number of mild asthma exacerbations, in one year, when compared with titration against BTS guidelines. To test this hypothesis the investigators propose a primary care, parallel treatment, patient blinded study in which matched groups of asthmatic patients will be treated in accordance either with BTS guidelines or with our treatment algorithm dependent on mannitol challenge result. Purpose of the study is to evaluate the efficacy of a treatment algorithm based on the measurement of airway hyperresponsiveness to mannitol challenge, a surrogate marker of airway inflammation, in the long term treatment of asthma in comparison to BTS guidelines.

Conditions

Interventions

TypeNameDescription
OTHERmannitol (an airway challenge agent)

Timeline

Start date
2004-03-01
Primary completion
2010-02-01
First posted
2010-10-07
Last updated
2010-10-07

Source: ClinicalTrials.gov record NCT01216579. Inclusion in this directory is not an endorsement.